Clinical Trial Update: Sublingual Immunotherapy In Alternaria-Induced Rhinitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of sublingual immunotherapy for Alternaria-induced allergic rhinitis (with asthma) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• Sublingual immunotherapy (Sublingual immunotherapy)

Snippet

Sponsor: University of Genova | Conditions: Allergic Rhinitis (w/w Asthma) Due to Alternaria Alternata | Phase 4 | Status: COMPLETED